In light of the findings that SMARCE1 promotes ovarian cancer invasion in vitro, we next assessed the in vivo function of SMARCE1 by using an orthotopic mouse model of OVCAR8-derived tumor formation. Here, SMARCE1 is linked to ovarian carcinoma.